Mark E. Bunnage, EVP, Chief Scientific Officer: Vertex Pharmaceuticals VRTX Planned sale · Filed 02/17

Trade details

Type: Planned sale notice
Stock: Vertex Pharmaceuticals VRTX
Person: Mark E. BunnageEVP, Chief Scientific Officer
Planned sale date: 26/02/17
Filed: 26/02/17

More to sell after $941.2K in 3 months

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/18~03/19

Mark E. Bunnage's recent trades

Mark E. BunnageEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$15K
33 sh
$15K
Filed 05/19
Traded 05/15
Mark E. BunnageEVP, Chief Scientific Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$15K
33 sh
$15K
Filed 05/15
Traded 05/15
Mark E. BunnageEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$301.5K
620 sh
$301.5K
Filed 02/26
Traded 02/25
Mark E. BunnageEVP, Chief Scientific Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$301.5K
620 sh
$301.5K
Filed 02/25
Traded 02/25
Mark E. BunnageEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.2M
2,437 sh
$1.2M
Filed 02/19
Traded 02/17

Mark E. Bunnage, Chief Officer — plans to sell 2,437 sh of Vertex Pharmaceuticals VRTX · $1.2M · around 02/17 · 10b5-1 plan | Whalegun